Applied BioCodeTPE:6598 74 Market Cap is NT$2,349.4 Mil as of Jun. 30, 2026. GuruFocus rates TPE:6598 with a GF Score™ of 74/100 and a GF Value™ of NT$23.33 (Fairly Valued). The stock has 6 warning signs investors should review. Among 867 Medical Devices & Instruments companies, Applied BioCode ranks worse than 55.36% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Applied BioCode's share price for the quarter that ended in Dec. 2025 was NT$22. Applied BioCode's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 102.8 Mil. Therefore, Applied BioCode's market cap for the quarter that ended in Dec. 2025 was NT$2,261.8 Mil.
Applied BioCode's quarterly market cap
increased
from Jun. 2025 (NT$2,020.0 Mil) to Sep. 2025 (NT$2,431.2 Mil) but then
declined
from Sep. 2025 (NT$2,431.2 Mil) to Dec. 2025 (NT$2,261.8 Mil).
Applied BioCode's annual market cap
increased
from Dec. 2023 (NT$2,068.7 Mil) to Dec. 2024 (NT$2,071.2 Mil) and
increased
from Dec. 2024 (NT$2,071.2 Mil) to Dec. 2025 (NT$2,261.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Applied BioCode's Enterprise Value for Today is NT$1,839.4 Mil.
Applied BioCode (TPE:6598) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Applied BioCode Market Cap Related Terms
Applied BioCode Market Cap Historical Data
* Premium members only.
The historical data trend for Applied BioCode's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Applied BioCode's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Applied BioCode Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's Market Cap distribution charts can be found below:
* The bar in red indicates where Applied BioCode's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Applied BioCode's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied BioCode (TPE:6598) has a Market Cap of NT$2,349.4 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Applied BioCode and its competitors. According to the industry distribution chart, Applied BioCode ranks #480 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 55.4%.
Is Applied BioCode's Market Cap too high?
Applied BioCode's current Market Cap is NT$2,349.4 Mil. Based on the distribution chart, Applied BioCode ranks #480 out of 867 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Applied BioCode has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Applied BioCode's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Applied BioCode ranks #480 out of 867 companies for Market Cap. This places Applied BioCode in the lower half of its industry. The industry median Market Cap is 120.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.18, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Applied BioCode and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Applied BioCode's current Market Cap is NT$2,349.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied BioCode stock overvalued right now?
Based on GuruFocus' analysis, Applied BioCode (TPE:6598) is currently considered Fairly Valued. The stock's GF Value™ is NT$23.33, compared to a current price of NT$22.85 — trading 2.1% below its estimated fair value. The current Market Cap is NT$2,349.4 Mil. Applied BioCode's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Applied BioCode (TPE:6598), the current Market Cap is NT$2,349.4 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Applied BioCode (TPE:6598) Overvalued in 2026?
Based on GuruFocus' analysis, Applied BioCode stock appears to be undervalued.
The current stock price of NT$22.85 is trading 2.1% below its estimated GF Value™ of NT$23.33.
GuruFocus considers Applied BioCode to be Fairly Valued.
Key valuation signals for TPE:6598:
Market Cap: NT$2,349.4 Mil
GF Value™: NT$23.33 vs. price of NT$22.85 (2.1% below fair value)
No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
74GF Score
Get the complete analysis for TPE:6598
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6598 has been successfully added to your 
